These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Elevation of cortical serotonin transporter activity upon peripheral immune challenge is regulated independently of p38 mitogen-activated protein kinase activation and transporter phosphorylation. Schwamborn R; Brown E; Haase J J Neurochem; 2016 May; 137(3):423-35. PubMed ID: 26924154 [TBL] [Abstract][Full Text] [Related]
5. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Zhu CB; Blakely RD; Hewlett WA Neuropsychopharmacology; 2006 Oct; 31(10):2121-31. PubMed ID: 16452991 [TBL] [Abstract][Full Text] [Related]
6. p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse. Robson MJ; Quinlan MA; Margolis KG; Gajewski-Kurdziel PA; Veenstra-VanderWeele J; Gershon MD; Watterson DM; Blakely RD Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10245-E10254. PubMed ID: 30297392 [TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-induced serotonin transporter up-regulation involves PKG-I and p38MAPK activation partially through A3 adenosine receptor. Zhao R; Wang S; Huang Z; Zhang L; Yang X; Bai X; Zhou D; Qin Z; Du G Biosci Trends; 2015 Dec; 9(6):367-76. PubMed ID: 26781794 [TBL] [Abstract][Full Text] [Related]
8. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Zhu CB; Hewlett WA; Feoktistov I; Biaggioni I; Blakely RD Mol Pharmacol; 2004 Jun; 65(6):1462-74. PubMed ID: 15155839 [TBL] [Abstract][Full Text] [Related]
9. Rare Opportunities for Insights Into Serotonergic Contributions to Brain and Bowel Disorders: Studies of the SERT Ala56 Mouse. Stilley SE; Blakely RD Front Cell Neurosci; 2021; 15():677563. PubMed ID: 34149362 [TBL] [Abstract][Full Text] [Related]
10. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. Samuvel DJ; Jayanthi LD; Bhat NR; Ramamoorthy S J Neurosci; 2005 Jan; 25(1):29-41. PubMed ID: 15634764 [TBL] [Abstract][Full Text] [Related]
11. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304). Ansah TA; Ramamoorthy S; Montañez S; Daws LC; Blakely RD J Pharmacol Exp Ther; 2003 Jun; 305(3):956-65. PubMed ID: 12626658 [TBL] [Abstract][Full Text] [Related]
12. p38 MAP kinase activation does not stimulate serotonin transport in rat brain: Implications for sickness behaviour mechanisms. Andreetta F; Barnes NM; Wren PB; Carboni L Life Sci; 2013 Jul; 93(1):30-37. PubMed ID: 23727352 [TBL] [Abstract][Full Text] [Related]
13. Monitoring mouse serotonin transporter internalization in stem cell-derived serotonergic neurons by confocal laser scanning microscopy. Lau T; Horschitz S; Bartsch D; Schloss P Neurochem Int; 2009; 54(3-4):271-6. PubMed ID: 19121357 [TBL] [Abstract][Full Text] [Related]
14. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360 [TBL] [Abstract][Full Text] [Related]
15. Quinlan MA; Robson MJ; Ye R; Rose KL; Schey KL; Blakely RD Front Mol Neurosci; 2020; 13():89. PubMed ID: 32581705 [TBL] [Abstract][Full Text] [Related]
16. Functional and pathological consequences of being fast on the uptake: Protein kinase G and p38α MAPK regulation of serotonin transporters. Gajeswski-Kurdziel PA; Walsh AE; Blakely RD Curr Res Physiol; 2024; 7():100117. PubMed ID: 38298474 [TBL] [Abstract][Full Text] [Related]
17. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. Zhu CB; Carneiro AM; Dostmann WR; Hewlett WA; Blakely RD J Biol Chem; 2005 Apr; 280(16):15649-58. PubMed ID: 15728187 [TBL] [Abstract][Full Text] [Related]
18. Quantitative trait loci mapping and gene network analysis implicate protocadherin-15 as a determinant of brain serotonin transporter expression. Ye R; Carneiro AM; Han Q; Airey D; Sanders-Bush E; Zhang B; Lu L; Williams R; Blakely RD Genes Brain Behav; 2014 Mar; 13(3):261-75. PubMed ID: 24405699 [TBL] [Abstract][Full Text] [Related]
19. Enteropathogenic infections modulate intestinal serotonin transporter (SERT) function by activating Toll-like receptor 2 (TLR-2) in Crohn's disease. Qasem A; Naser AE; Naser SA Sci Rep; 2021 Nov; 11(1):22624. PubMed ID: 34799637 [TBL] [Abstract][Full Text] [Related]
20. cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake. Steiner JA; Carneiro AM; Wright J; Matthies HJ; Prasad HC; Nicki CK; Dostmann WR; Buchanan CC; Corbin JD; Francis SH; Blakely RD Mol Brain; 2009 Aug; 2():26. PubMed ID: 19656393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]